1QZ.DE1QZ.DEXETRA
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank50
3Y CAGR-44.4%
5Y CAGR-21.7%
Studio
Year-over-Year Change

Year-over-year research & development expense growth

3Y CAGR
-44.4%/yr
Annual compound
5Y CAGR
-21.7%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive growthRecovering
PeriodValue
202513.78%
202410.85%
2023-43.06%
202280.12%
2021375.31%
202046.85%
20190.00%